Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Biora Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of BIOR: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders5755−2
Shares48.5M51.0M+2.58M (+5.3%)
Value$101.3M$59.2M−$42.1M (−41.6%)

New holders (13)

Institutions that held Biora Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to BIOR in Q1 2022
InstitutionSharesValue% of portfolio
Virtu Financial LLC371,604$431.0K0.03%
Barclays PLC144,927$168.0K0.00%
Man Group plc134,817$156.0K0.00%
HRT Financial LP78,270$90.0K0.00%
Group One Trading, L.P.47,704$55.0K0.00%
Independent Advisor Alliance37,473$43.0K0.00%
Claudia M.P. Batlle, CRP (R) LLC20,000$23.0K0.01%
Cambridge Investment Research Advisors, Inc.15,100$18.0K0.00%
Goldman Sachs Group Inc14,000$16.0K0.00%
McCollum Christoferson Group LLC13,200$15.0K0.00%
Northwestern Mutual Wealth Management Co2,000$2.00K0.00%
US Bancorp387$00.00%
Hantz Financial Services, Inc.75$00.00%

Sold out (15)

Institutions that held Biora Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.